ORALAIR

This brand name is authorized in Austria, Canada, Estonia, Spain, France, Croatia, Ireland, Lithuania, Netherlands, New Zealand, Poland, Romania, Tunisia

Active ingredients

The drug ORALAIR contains one active pharmaceutical ingredient (API):

1 Grass pollen

Read about Grass pollen

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
ORALAIR Tablets	FDA, National Drug Code (US)	MPI, US: SPL/PLR

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
V01AA02	Grass pollen	V Various → V01 Allergens → V01A Allergens → V01AA Allergen extracts
Discover more medicines within V01AA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: CA	Health Products and Food Branch	Identifier(s): 02381885, 02381893
Country: EE	Ravimiamet	Identifier(s): 1415887, 1415911, 1415922
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 71953, 71954
Country: FR	Base de données publique des médicaments	Identifier(s): 60425707, 62764332
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1037548, 1037549, 1055021
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 205648, 205656
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 14761, 14762
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100226818, 100226853
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W55365001, W55366001, W55366002
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 3653041, 3653042